| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_RP11-124N14.3_0000600 | Intergenic-Exon | chr10:17271866-17275669 | chr10:17229867-17233670 | 119 nt | 0.6555 |
| hsa_RP11-124N14.3_0000700 | Intergenic-Exon | chr10:17271866-17275840 | chr10:17229867-17233841 | 168 nt | 0.4702 |
| hsa_RP11-124N14.3_0000800 | Intergenic-Exon | chr10:17271908-17275618 | chr10:17229909-17233619 | 171 nt | 0.5614 |
| hsa_RP11-124N14.3_0000900 | Intergenic-Exon | chr10:17271908-17275847 | chr10:17229909-17233848 | 156 nt | 0.5769 |
| hsa_RP11-124N14.3_0001000 | Intergenic-Exon | chr10:17271953-17275603 | chr10:17229954-17233604 | 93 nt | 0.5484 |
| hsa_RP11-124N14.3_0001100 | Exon-Intron | chr10:17275542-17275992 | chr10:17233543-17233993 | 364 nt | 0.4643 |
| hsa_RP11-124N14.3_0001200 | Exon-Exon | chr10:17275619-17276805 | chr10:17233620-17234806 | 114 nt | 0.5965 |
| hsa_RP11-124N14.3_0001300 | Exon-Intergenic | chr10:17275619-17278342 | chr10:17233620-17236343 | 666 nt | 0.5045 |
| hsa_RP11-124N14.3_0001400 | Exon-Exon | chr10:17275846-17276789 | chr10:17233847-17234790 | 85 nt | 0.5294 |
| hsa_RP11-124N14.3_0001500 | Intron-Intron | chr10:17276455-17276590 | chr10:17234456-17234591 | 136 nt | 0.4191 |
A study in humans demonstrated that the circVIM is upregulated in de novo acute myeloid leukemia patients with a normal karyotype compared to healthy controls, supporting its potential as a diagnostic biomarker [Di Agostino et al. DOI:10.3389/fcell.2020.00389].